Search results
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth
Investing.com· 3 days agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
Is Pfizer the Best Dividend Stock for You? | The Motley Fool
The Motley Fool· 6 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (PFE 1.63%) benefitted...
How To Earn $500 A Month From Pfizer Stock
Benzinga via AOL· 7 days agoShares of Pfizer Inc. (NYSE:PFE) closed higher during Thursday's session, with the company's stock adding around 10% over the past month. Pfizer ...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 2 days agoPfizer's stock has been a disappointment in recent years as the hype from its COVID vaccine and pill...
Pfizer (NYSE:PFE) Trading 0.3% Higher
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.3% during mid-day trading on Tuesday . The company traded as high as $29.73 and last traded at $29.41. 9,834,266 shares ...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Pfizer Inc. (NYSE:PFE) – Experts See The Stock A Different Way Today – Marketing Sentinel
Marketing Sentinel· 2 days agoThe share price’s 52-week low was $25.20, which indicates that the recent value has risen by an impressive 14.23% since then. We note from Pfizer Inc.’s ...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 15 hours agoPfizer and Moderna are also planning to prepare JN.1-focused boosters. Novavax stock has been on a...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 2 days agoAbbVie: A top dividend growth stock AbbVie is a powerhouse dividend payer. Apart from its superb yield of 3.87%, the company has also...
Potential Price Increase for Pfizer Inc.
Knox Daily· 4 days agoArgus downgraded its Pfizer Inc. [PFE] rating to a Hold from a a Buy in a research...revised their coverage, including Guggenheim’s analysts, who began to cover the
